June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
A modified Pediatric Eye Questionnaire (PedEyeQ) to determine quality of life and functional vision among patients with late-infantile CLN2 disease
Author Affiliations & Notes
  • Simon Dulz
    Ophthalmology, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Martin Stephan Spitzer
    Ophthalmology, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Yevgeniya Atiskova
    Ophthalmology, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Footnotes
    Commercial Relationships   Simon Dulz Neurogene Inc., Code C (Consultant/Contractor), RegenxBio Inc., Code C (Consultant/Contractor), Biomarin Inc., Code C (Consultant/Contractor), Taysha Gene Thx Inc., Code C (Consultant/Contractor); Martin Spitzer Neurogene Inc., Code C (Consultant/Contractor); Yevgeniya Atiskova Neurogene Inc., Code C (Consultant/Contractor), Biomarin Inc., Code C (Consultant/Contractor)
  • Footnotes
    Support  The work has been supported by Neurogene Inc.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4122. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Simon Dulz, Martin Stephan Spitzer, Yevgeniya Atiskova; A modified Pediatric Eye Questionnaire (PedEyeQ) to determine quality of life and functional vision among patients with late-infantile CLN2 disease. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4122.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Vision loss is a prominent feature of neuronal ceroid lipofuscinosis Type 2 (CLN2) Batten disease, yet cognitive, motor, and language impairments limit reliable measurement of visual acuity (VA), functional vision and quality of life assessment using standard methods. In order to establish additional outcome measures in this cohort, we assessed the pediatric Eye Questionnaire (PedEyeQ) among CLN2 caregivers.

Methods : Cross sectional cohort study assessing a modified PedEyeQ consisting of a twenty-two items questionnaire involving four major domains (functional vision; impact on parent and family; worry about child`s eye condition; worry about functional vision). The total score of the questionnaire was correlated with age and the central retinal thickness (CRT) assessed by optical coherence tomography (OCT).
In order to evaluate the importance of all four domain subscores, we correlated each domain subscore with CRT.
Auch PL korrellieren?
Bei Fragebögen muss doch immer Validität überprüft werden oder?

Results : 20 caregivers of twenty genetically verified CLN2 patients were interviewed with a modified PedEyeQ. A significant positive correlation was observed between the total PedEyeQ score and age (p = 0.492) as well as CRT (p = 0.741). In particularly, the functional vision domain correlated significantly (p = 0.758) with CRT.

Conclusions : The modified PedEyeQ score resembles a valuable exploratory outcome measure to assess quality of life and functional vision in otherwise uncooperative patients with CLN2 disease. We advocate the utility and the exploration of the modified PedEyeQ in all subtypes of neuronal ceroid lipofuscinoses.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×